» Articles » PMID: 38780014

Evidence for a Novel Neuronal Mechanism Driving Alzheimer's Disease, Upstream of Amyloid

Overview
Specialties Neurology
Psychiatry
Date 2024 May 23
PMID 38780014
Authors
Affiliations
Soon will be listed here.
Abstract

This perspective offers an alternative to the amyloid hypothesis in the etiology of Alzheimer's disease (AD). We review evidence for a novel signaling mechanism based on a little-known peptide, T14. T14 could drive neurodegeneration as an aberrantly activated process of plasticity selective to interconnecting subcortical nuclei, the isodendritic core, where cell loss starts at the pre-symptomatic stages of the disease. Each of these cell groups has the capacity to form T14, which can stimulate production of p-Tau and β-amyloid, suggestive of an upstream driver of neurodegeneration. Moreover, results in an animal AD model show that antagonism of T14 with a cyclated variant, NBP14, prevents formation of β-amyloid, and restores cognitive function to that of wild-type counterparts. Any diagnostic and/or therapeutic strategy based on T14-NBP14 awaits validation in clinical trials. However, an understanding of this novel signaling system could bring much-needed fresh insights into the progression of cell loss underlying AD. HIGHLIGHTS: The possible primary mechanism of neurodegeneration upstream of amyloid. Primary involvement of selectively vulnerable subcortical nuclei, isodendritic core. Bioactive peptide T14 trophic in development but toxic in context of mature brain. Potential for early-stage biomarker to detect Alzheimer's disease. Effective therapeutic halting neurodegeneration, validated already in 5XFAD mice.

Citing Articles

Exosomes in Regulating miRNAs for Biomarkers of Neurodegenerative Disorders.

Sivalingam A, Sureshkumar D Mol Neurobiol. 2025; .

PMID: 39918711 DOI: 10.1007/s12035-025-04733-8.


A Novel 14mer Peptide Inhibits Autophagic Flux via Selective Activation of the mTORC1 Signalling Pathway: Implications for Alzheimer's Disease.

Garcia Porta C, Mahfooz K, Komorowska J, Garcia-Rates S, Greenfield S Int J Mol Sci. 2024; 25(23).

PMID: 39684549 PMC: 11641777. DOI: 10.3390/ijms252312837.


Oxidative Stress Triggers a Pivotal Peptide Linked to Alzheimer's Disease.

Evans N, Mahfooz K, Garcia-Rates S, Greenfield S Int J Mol Sci. 2024; 25(22).

PMID: 39596477 PMC: 11594494. DOI: 10.3390/ijms252212413.


From Plaques to Pathways in Alzheimer's Disease: The Mitochondrial-Neurovascular-Metabolic Hypothesis.

Kazemeini S, Nadeem-Tariq A, Shih R, Rafanan J, Ghani N, Vida T Int J Mol Sci. 2024; 25(21).

PMID: 39519272 PMC: 11546801. DOI: 10.3390/ijms252111720.


Rodent Models of Alzheimer's Disease: Past Misconceptions and Future Prospects.

Collins H, Greenfield S Int J Mol Sci. 2024; 25(11).

PMID: 38892408 PMC: 11172947. DOI: 10.3390/ijms25116222.


References
1.
RAMON-MOLINER E, Nauta W . The isodendritic core of the brain stem. J Comp Neurol. 1966; 126(3):311-35. DOI: 10.1002/cne.901260301. View

2.
Stewart T, Davis F . An element for development: Calcium signaling in mammalian reproduction and development. Biochim Biophys Acta Mol Cell Res. 2019; 1866(7):1230-1238. DOI: 10.1016/j.bbamcr.2019.02.016. View

3.
Eimerl S, Schramm M . The quantity of calcium that appears to induce neuronal death. J Neurochem. 1994; 62(3):1223-6. DOI: 10.1046/j.1471-4159.1994.62031223.x. View

4.
Rocha S, Garcia Rates S, Moswete T, Kalleberg K, Villa A, Harcup J . A novel peptide 'T14' reflects age and photo-aging in human skin. Aging (Albany NY). 2023; 15(12):5279-5289. PMC: 10333063. DOI: 10.18632/aging.204844. View

5.
van Dyck C, Swanson C, Aisen P, Bateman R, Chen C, Gee M . Lecanemab in Early Alzheimer's Disease. N Engl J Med. 2022; 388(1):9-21. DOI: 10.1056/NEJMoa2212948. View